Congress is Expected to Bring PBM Transparency Legislation
Any federal bill regulating the pharmacy benefit management (PBM) industry that makes it to President Joe Biden’s desk will likely be focused on transparency issues and not on providing broad changes to the industry. Robyn Crosson, JD, Vice President, Government Relations at Navitus Health Solutions was one of several speakers to share her thoughts at the Pharmacy Benefit Management Institute’s annual conference in Orlando.
MORE ABOUT Robyn Crosson
Robyn Crosson is the Vice President of Government Relations at Navitus, where she provides strategic direction on government relations thought-leadership initiatives. She oversees building external relationships with state and federal governments, lobbyists and stakeholders. Her team focuses on legislation and proposed rules/regulations concerning the pharmaceutical, PBM and health care industries.
Stay Informed and Connected
Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.
Navigating with a trusted partner
Now Available: 9th Annual Drug Trend Report
Our Drug Trend Report provides a clear view of the trends shaping pharmacy benefits today, along with strategies that are delivering real savings without compromising care.
Related blogs
Navigating Healthcare and Improving Outcomes
PBM 101: Demystifying the Complex World of Specialty Drugs
Unless you work in the pharmacy benefit management (PBM) industry, it’s easy to assume that a “specialty drug” is simply a more expensive prescription. In reality, specialty medications sit in a separate category, with different rules and far bigger consequences…
